CEACAM3 Antikörper (AA 177-226)
-
- Target Alle CEACAM3 Antikörper anzeigen
- CEACAM3 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3))
-
Bindungsspezifität
- AA 177-226
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CEACAM3 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human CEACAM3
- Homologie
- Percent identity by BLAST analysis:
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa177-226 of human CEACAM3 (P40198, NP_001806). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla (100%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product CEACAM3 Primärantikörper
-
-
- Applikationshinweise
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 16, pp. 10364-9, (2002) (PubMed).
: "Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex." in: The Journal of biological chemistry, Vol. 274, Issue 32, pp. 22686-92, (1999) (PubMed).
: "Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis." in: The EMBO journal, Vol. 18, Issue 13, pp. 3586-95, (1999) (PubMed).
: "Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition." in: Science (New York, N.Y.), Vol. 284, Issue 5411, pp. 156-9, (1999) (PubMed).
: "
-
Nitric oxide-induced genotoxicity, mitochondrial damage, and apoptosis in human lymphoblastoid cells expressing wild-type and mutant p53." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Issue 16, pp. 10364-9, (2002) (PubMed).
-
- Target
- CEACAM3 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3))
- Andere Bezeichnung
- CD66d / CEACAM3 (CEACAM3 Produkte)
- Synonyme
- CD66D antikoerper, CEA antikoerper, CGM1 antikoerper, W264 antikoerper, W282 antikoerper, CGM4AA antikoerper, Cea antikoerper, Ceacam5 antikoerper, Cear antikoerper, Cgm1 antikoerper, Cgm4 antikoerper, RATCEAA antikoerper, RATCGM4AA antikoerper, EG384557 antikoerper, Psg24 antikoerper, cea12 antikoerper, carcinoembryonic antigen related cell adhesion molecule 3 antikoerper, carcinoembryonic antigen-related cell adhesion molecule 3 antikoerper, CEACAM3 antikoerper, Ceacam3 antikoerper
- Hintergrund
-
Name/Gene ID: CEACAM3
Family: CEA
Synonyms: CEACAM3, Carcinoembryonic antigen CGM1, CGM1, CD66d antigen, CEA, W264, W282, CD66D - Gen-ID
- 1084
- NCBI Accession
- NP_001806
- UniProt
- P40198
-